Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6

NCT03054220 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Jules Desmeules